title: Return of infliximab efficacy after total knee arthroplasty in a patient with rheumatoid arthritis.
authors.forename: Hiroe
authors.initials: H
authors.lastname: Toki
authors.forename: Shigeki
authors.initials: S
authors.lastname: Momohara
authors.forename: Katsunori
authors.initials: K
authors.lastname: Ikari
authors.forename: Koichiro
authors.initials: K
authors.lastname: Kawamura
authors.forename: So
authors.initials: S
authors.lastname: Tsukahara
authors.forename: Takeshi
authors.initials: T
authors.lastname: Mochizuki
authors.forename: Eri
authors.initials: E
authors.lastname: Sato
authors.forename: Hisashi
authors.initials: H
authors.lastname: Yamanaka
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000601:surgery*; D019645:Arthroplasty, Replacement, Knee; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab